Reasons why LUTH cancer centre has yet to begin operation- Prof Chris Bode Chief Medical Director


Lagos University Teaching Hospital, Prof Chris Bode
Chief Medical Director, has said the equipment at the new Nigeria Sovereign Investment Authority/LUTH cancer treatment centre is undergoing necessary calibrations and fine tuning to align with international standard before the centre begins operation.

Bode, during the visit of the acting Director of the United States Trade and Development Agency, Mr Thomas Hardy, to the centre, said the facility would open for patients on May 1, 2019.

The CMD said the machines would perform optimally for the next 10 years as payment had been made for maintenance, routine services, and breakdowns.

Bode noted that once the centre began operation, it would reduce medical tourism to other countries, adding that the services at the new centre would be affordable than travelling abroad for cancer treatment.

Hardy, in his response, said the facility was a testament to the good leadership of the hospital’s management.

Hardy said the agency he represented was interested in investing in people that had a similar vision and ability to achieve great things.

“The leadership of LUTH came to the United States of America; we introduced them to American technology and cancer treatment solutions in a bid to transform Nigeria’s health care system for accessible and quality care. We will continue to be in contact with the team to find other opportunities,” Hardy said.

Facebook Comments
Disclaimer: does not guarantee any specific results as a result of the procedures mentioned here and the results may vary from person to person. The topics in these pages including text, graphics, videos and other material contained on this website are for informational purposes only and not to be substituted for professional medical advice.

Leave a Reply